Category : Search result: GLP1 drugs market


Generic Semaglutide to Create Rs 50,000 Cr Market

The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.

Indian Pharma Firms Eye Licensing Deals for Obesity Drugs

As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.

Aurobindo Pharma buys Khandelwal Labs unit for ₹325 cr

Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.

Bengaluru engineer arrested for making drugs at home

A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.

GLP-1 Drugs Show Benefits Beyond Weight Loss

New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.

Lack of Drug Inspectors Hampers Action on Spurious Drugs

A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.

Himachal Leads Nation in Substandard Drugs: 49 Fail

Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.

Orry Mobbed by Fans at Mumbai Police Station

Social media star Orry faced fan frenzy while appearing before Mumbai Police in the ₹252 crore drug case. Watch the dramatic scenes unfold as he arrives for questioning.

Indian Companies Set for Semaglutide Device Windfall

Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.

Page 1 of 4